Takehiro Otoshi

722 total citations
30 papers, 489 citations indexed

About

Takehiro Otoshi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Takehiro Otoshi has authored 30 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Physiology. Recurrent topics in Takehiro Otoshi's work include Lung Cancer Treatments and Mutations (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Respiratory Support and Mechanisms (4 papers). Takehiro Otoshi is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Respiratory Support and Mechanisms (4 papers). Takehiro Otoshi collaborates with scholars based in Japan, United States and Israel. Takehiro Otoshi's co-authors include Tatsuya Nagano, Yoshihiro Nishimura, Atsushi Nakagawa, Kojiro Otsuka, Keisuke Tomii, Daichi Fujimoto, Kazuma Nagata, Motoko Tachihara, Takahisa Kawamura and Kyoko Otsuka and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Takehiro Otoshi

29 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takehiro Otoshi Japan 11 332 213 62 60 46 30 489
Yunjoo Im South Korea 12 246 0.7× 67 0.3× 52 0.8× 78 1.3× 39 0.8× 41 487
Cheng‐Yu Chang Taiwan 11 251 0.8× 171 0.8× 77 1.2× 27 0.5× 18 0.4× 29 388
Ferah Ece Türkiye 9 302 0.9× 70 0.3× 174 2.8× 86 1.4× 42 0.9× 22 515
Catherine Read Australia 15 618 1.9× 56 0.3× 184 3.0× 51 0.8× 41 0.9× 27 759
Makoto Hibino Japan 10 139 0.4× 131 0.6× 44 0.7× 32 0.5× 62 1.3× 49 334
Akshat Malik India 12 85 0.3× 98 0.5× 171 2.8× 65 1.1× 31 0.7× 52 496
Suqin Ben China 11 144 0.4× 81 0.4× 44 0.7× 67 1.1× 47 1.0× 21 451
Geraint Lloyd United Kingdom 16 438 1.3× 100 0.5× 305 4.9× 54 0.9× 16 0.3× 24 693
Hande Köksal Türkiye 12 91 0.3× 65 0.3× 190 3.1× 13 0.2× 20 0.4× 44 407
Deyun Cheng China 13 232 0.7× 41 0.2× 40 0.6× 42 0.7× 144 3.1× 33 437

Countries citing papers authored by Takehiro Otoshi

Since Specialization
Citations

This map shows the geographic impact of Takehiro Otoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiro Otoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiro Otoshi more than expected).

Fields of papers citing papers by Takehiro Otoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehiro Otoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiro Otoshi. The network helps show where Takehiro Otoshi may publish in the future.

Co-authorship network of co-authors of Takehiro Otoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Takehiro Otoshi. A scholar is included among the top collaborators of Takehiro Otoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiro Otoshi. Takehiro Otoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagano, Tatsuya, Reina Sekiya, Takehiro Otoshi, et al.. (2024). Effects of Tongue Strength Training on Patients with Mild to Moderate Sleep-disordered Breathing: A Randomized Controlled Trial. Progress in Rehabilitation Medicine. 9(0). n/a–n/a. 3 indexed citations
2.
Miura, Akihiro, Junichi Tanaka, Takehiro Otoshi, et al.. (2023). Conditional blastocyst complementation of a defective Foxa2 lineage efficiently promotes the generation of the whole lung. eLife. 12. 10 indexed citations
3.
Katsurada, Masahiro, Motoko Tachihara, Naoko Katsurada, et al.. (2022). Randomized single-blind comparative study of the midazolam/pethidine combination and midazolam alone during bronchoscopy. BMC Cancer. 22(1). 539–539. 4 indexed citations
4.
Otoshi, Takehiro, Tatsuya Nagano, Jonguk Park, et al.. (2022). The Gut Microbiome as a Biomarker of Cancer Progression Among Female Never-smokers With Lung Adenocarcinoma. Anticancer Research. 42(3). 1589–1598. 9 indexed citations
5.
Katsurada, Naoko, Motoko Tachihara, Naoe Jimbo, et al.. (2021). Yield of tumor samples with a large guide-sheath in endobronchial ultrasound transbronchial biopsy for non-small cell lung cancer: A prospective study. PLoS ONE. 16(10). e0259236–e0259236. 6 indexed citations
6.
Otoshi, Takehiro, Tatsuya Nagano, Shintaro Izumi, et al.. (2021). A novel automatic cough frequency monitoring system combining a triaxial accelerometer and a stretchable strain sensor. Scientific Reports. 11(1). 9973–9973. 20 indexed citations
7.
8.
Otoshi, Takehiro, et al.. (2020). A rare case of parathyroid crisis with respiratory failure successfully treated using extracorporeal membrane oxygenation. Respiratory Medicine Case Reports. 30. 101088–101088. 1 indexed citations
9.
Katsurada, Masahiro, Tatsuya Nagano, Motoko Tachihara, et al.. (2019). Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer. Anticancer Research. 39(2). 815–825. 74 indexed citations
10.
Otoshi, Takehiro, Tatsuya Nagano, Yasuhiro Funada, et al.. (2019). A Cross-sectional Survey of the Clinical Manifestations and Underlying Illness of Cough. In Vivo. 33(2). 543–549. 8 indexed citations
11.
Nagano, Tatsuya, Takehiro Otoshi, Daisuke Hazama, et al.. (2019). <p>Novel cancer therapy targeting microbiome</p>. OncoTargets and Therapy. Volume 12. 3619–3624. 26 indexed citations
12.
Kataoka, Yuki, Hirotaka Matsumoto, Emiko Saito, et al.. (2018). Influence of social determinants of health on patients with advanced lung cancer: a prospective cohort study. BMJ Open. 8(10). e023152–e023152. 6 indexed citations
13.
Kataoka, Yuki, Yu Uneno, Takehiro Otoshi, et al.. (2018). The reporting quality of prediction models in oncology journals: A systematic review. Annals of Oncology. 29. ix171–ix171. 3 indexed citations
14.
15.
Otoshi, Takehiro, Yuki Kataoka, Atsushi Nakagawa, Kojiro Otsuka, & Keisuke Tomii. (2016). Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study. Lung. 194(3). 475–481. 6 indexed citations
16.
Nagata, Kazuma, Takeshi Morimoto, Daichi Fujimoto, et al.. (2015). Efficacy of High-Flow Nasal Cannula Therapy in Acute Hypoxemic Respiratory Failure: Decreased Use of Mechanical Ventilation. Respiratory Care. 60(10). 1390–1396. 47 indexed citations
17.
Fujimoto, Daichi, Takeshi Morimoto, Ryoji Kato, et al.. (2014). Analysis of advanced lung cancer patients diagnosed following emergency admission. European Respiratory Journal. 45(4). 1098–1107. 10 indexed citations
18.
Fujimoto, Daichi, Hiroyuki Ueda, Ryoji Kato, et al.. (2014). Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis. Clinical & Experimental Metastasis. 31(5). 543–551. 47 indexed citations
19.
Tanaka, Kosuke, Akito Hata, Reiko Kaji, et al.. (2013). Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation. Journal of Thoracic Oncology. 8(7). 892–898. 41 indexed citations
20.
Fujimoto, Daichi, Keisuke Tomii, Takehiro Otoshi, et al.. (2013). Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma. Lung Cancer. 80(2). 159–164. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunjoo Im Breakdown of academic impact, for papers by Cheng‐Yu Chang Breakdown of academic impact, for papers by Ferah Ece Breakdown of academic impact, for papers by Catherine Read Breakdown of academic impact, for papers by Makoto Hibino Breakdown of academic impact, for papers by Akshat Malik Breakdown of academic impact, for papers by Suqin Ben Breakdown of academic impact, for papers by Geraint Lloyd Breakdown of academic impact, for papers by Hande Köksal Breakdown of academic impact, for papers by Deyun Cheng
Rankless by CCL
2026